Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis

Jiang, Houbo, Ren, Yong, Zhao, Jinghui, Feng, Jian·2004·Human Molecular Genetics

Cited by (239)

Items 101–200 of 239

  1. PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome
    Angela E. Scheuerle, Kathleen Wilson · 2011 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  2. Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila
    Dario C. Angeles, Patrick Ho, Ling Ling Chua, Cheng Wang, Yann Wan Yap, C. Ng, Zhidong Zhou, Kah‐Leong Lim, Zbigniew K. Wszołek, Hong Y. Wang et al. · 2014 · Human Molecular Genetics
  3. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis
    Ravi Shankar Akundi, Lianteng Zhi, Hansruedi Büeler · 2011 · Neurobiology of Disease
  4. Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling
    Anna Matton, Nodi Dehvari, Mónica Pérez‐Manso, Kelly Jean Thomas Craig, Elena Karpilovski, Mark Cookson, Richard F. Cowburn, Ángel Cedazo-Mı́nguez · 2009 · FEBS Journal
  5. Neuroprotective effect ofScutellaria baicalensison spinal cord injury in rats
    Tae Young Yune, Jee Y. Lee, Chun M. Cui, Ho C. Kim, Tae H. Oh · 2009 · Journal of Neurochemistry
  6. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function
    Chul Ju Hwang, Young‐Eun Kim, Dong Ju Son, Mi Hee Park, Dong‐Young Choi, Pil‐Hoon Park, Mats Hellström, Sang‐Bae Han, Ki‐Wan Oh, Eunkyung Park et al. · 2016 · Redox Biology
  7. Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra
    Linda B Moran, E. Croisier, Dawn C. Duke, Michail E. Kalaitzakis, Federico Roncaroli, Manuel Deprez, David Trevor Dexter, R. K. B. Pearce, Manuel B. Graeber · 2007 · Acta Neuropathologica
  8. Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson’s Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line
    Rong‐Tzong Tsai, Chia-Wen Tsai, Shih‐Ping Liu, Jia-Xin Gao, Yun-Hua Kuo, Pei‐Min Chao, Huey‐Shan Hung, Woei‐Cherng Shyu, Shinn‐Zong Lin, Ru‐Huei Fu · 2020 · International Journal of Molecular Sciences
  9. Molecular Aspects of Dopaminergic Neurodegeneration: Gene-Environment Interaction in Parkin Dysfunction
    Syed F. Ali, ZBIGNIEW K. BINIENDA, Syed Z. Imam · 2011 · International Journal of Environmental Research and Public Health
  10. Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: Implication in autosomal recessive juvenile Parkinsonism
    Leonardo Bonilla-Ramírez, Marlene Jiménez-Del-Río, Carlos Velez‐Pardo · 2012 · Gene
  11. Parkin Disrupts the α-Synuclein/Dopamine Transporter Interaction: Consequences Toward Dopamine-induced Toxicity
    Anna Moszczyńska, Jumana Saleh, Hongyu Zhang, Brian Vukusic, Frank J.S. Lee, Fang Liu · 2007 · Journal of Molecular Neuroscience
  12. The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration
    Scoty M. Hearst, L.R. Walker, Qingmei Shao, María Isabel Sánchez López, Dražen Raucher, Parminder J. S. Vig · 2011 · Neuroscience
  13. Carnosic Acid Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells by Inducing Autophagy Through an Enhanced Interaction of Parkin and Beclin1
    Chia‐Yuan Lin, Chia-Wen Tsai · 2016 · Molecular Neurobiology
  14. Restriction of trophic factors and nutrients induces PARKIN expression
    Klinkenberg, M., Gispert, S., Dominguez-Bautista, J. A., Braun, I., Auburger, G., Jendrach, M. · 2012 · neurogenetics
  15. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity
    Bin Liu, Roberta Traini, Bryan A. Killinger, Bernard Laurent Schneider, Anna Moszczyńska · 2013 · Experimental Neurology
  16. Systemic administration of PEP-1–SOD1 fusion protein improves functional recovery by inhibition of neuronal cell death after spinal cord injury
    Tae Young Yune, Jee Youn Lee, Mei Hua Jiang, Dae Won Kim, Soo Young Choi, Tae Hwan Oh · 2008 · Free Radical Biology and Medicine
  17. Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
    Hong Li, Houbo Jiang, Boyang Zhang, Jian Feng · 2018 · Journal of Parkinson s Disease
  18. Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
    Longping Yao, Jiayu Wu, Sümeyye Koç, Guohui Lu · 2021 · Frontiers in Cell and Developmental Biology
  19. Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells
    Yukiko Kuroda, Takao Mitsui, Makoto Kunishige, Toshio Matsumoto · 2006 · Biochemical and Biophysical Research Communications
  20. K252a Prevents Nigral Dopaminergic Cell Death Induced by 6-Hydroxydopamine through Inhibition of Both Mixed-Lineage Kinase 3/c-Jun NH2-Terminal Kinase 3 (JNK3) and Apoptosis-Inducing Kinase 1/JNK3 Signaling Pathways
    Jing Pan, Gang Wang, Hongqi Yang, Zhen Hong, Qin Xiao, Ru‐Jing Ren, Haiyan Zhou, Li Bai, Shengdi Chen · 2007 · Molecular Pharmacology
  21. Involvement of C/EBPβ-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis
    Enping Huang, Hongyan Huang, Tianshan Guan, Chao Liu, Dong Qu, Yue Xu, Jiao Yang, Lei Yan, Yahui Xiong, Ting Bo Liang et al. · 2019 · Toxicology Letters
  22. Recessive Parkinson's disease
    Shinichiro Kubo, Nobutaka Hattori, Yoshikuni Mizuno · 2006 · Movement Disorders
  23. The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
    Marc van der Vlag, Robbert Havekes, Pim R.A. Heckman · 2020 · European Journal of Neuroscience
  24. Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
    Sahar Avazzadeh, Jara M. Baena-Montes, Cameron Noah Keighron, Yajaira Feller Sánchez, Leo R. Quinlan · 2021 · Brain Sciences
  25. Parkin Co-regulated Gene (PACRG) is regulated by the ubiquitin–proteasomal system and is present in the pathological features of parkinsonian diseases
    Juliet Marie Taylor, Yun Ju Christine Song, Yue Ming Huang, Matthew James Farrer, Martin Bruce Delatycki, Glenda Margaret Halliday, Paul J. Lockhart · 2007 · Neurobiology of Disease
  26. Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene
    Valentina La Cognata, Rosario Iemmolo, Velia D’Agata, Soraya Scuderi, Filippo Drago, Mario Zappia, Sebastiano Cavallaro · 2014 · Current Genomics
  27. Expression pattern of parkin isoforms in lung adenocarcinomas
    Agata Grazia D’Amico, Grazia Maugeri, Gaetano Giuseppe Magro, Lucia Salvatorelli, Filippo Drago, Velia D’Agata · 2015 · Tumor Biology
  28. Induction of parkin expression in the presence of oxidative stress
    Yan Yang, Miratul M. K. Muqit, David S. Latchman · 2006 · European Journal of Neuroscience
  29. Dyrk1A phosphorylates parkin at Ser‐131 and negatively regulates its ubiquitin E3 ligase activity
    Eunju Im, Kwang Chul Chung · 2015 · Journal of Neurochemistry
  30. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson’s disease (PD) – A road to discovery?
    Kaavya Jayaramayya, Mahalaxmi Iyer, Dhivya Venkatesan, Venkatesh Balasubramanian, Arul Narayanasamy, Mohana Devi Subramaniam, Ssang‐Goo Cho, Balachandar Vellingiri · 2020 · Brain Research Bulletin
  31. Gene therapy targeting mitochondrial pathway in Parkinson’s disease
    Chi‐Jing Choong, Hideki Mochizuki · 2016 · Journal of Neural Transmission
  32. Pathologic and therapeutic implications for the cell biology of parkin
    Rakshita A. Charan, Matthew J. LaVoie · 2015 · Molecular and Cellular Neuroscience
  33. An aggregate-prone mutant of human glyceraldehyde-3-phosphate dehydrogenase augments oxidative stress-induced cell death in SH-SY5Y cells
    Hidemitsu Nakajima, Wataru Amano, Ayano Fukuhara, Takeya Kubo, Shouhei Misaki, Yasu‐Taka Azuma, Takashi Inui, Tadayoshi Takeuchi · 2009 · Biochemical and Biophysical Research Communications
  34. Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease
    Manuj Ahuja, Navneet Ammal Kaidery, Debashis Dutta, Otis C. Attucks, Eliot H. Kazakov, Irina G. Gazaryan, Mitsuyo Matsumoto, Kazuhiko Igarashi, Sudarshana M. Sharma, Bobby Thomas · 2022 · Antioxidants
  35. Programmed cell death‐2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease
    Jiro Fukae, Shigeto Sato, Kahori Shiba, Kenichi Sato, Hideo Mori, Philip A. Sharp, Yoshikuni Mizuno, Nobutaka Hattori · 2009 · FEBS Letters
  36. Programmed cell death and new discoveries in the genetics of parkinsonism
    Robert E. Burke · 2008 · Journal of Neurochemistry
  37. E3 Ubiquitin Ligases in Protein Quality Control Mechanism
    Deepak Chhangani, Ajay Prakash Joshi, Amit Mishra · 2012 · Molecular Neurobiology
  38. Plant Polyphenols as Neuroprotective Agents in Parkinson’s Disease Targeting Oxidative Stress
    Suet Lee Hor, Seong Lin Teoh, Wei Ling Lim · 2019 · Current Drug Targets
  39. Aromatic l -amino acid decarboxylase deficiency: a patient-derived neuronal model for precision therapies
    Giada Rossignoli, Karolin Krämer, Eleonora Lugarà, Haya Alrashidi, Simon A. S. Pope, Carmen De La Fuente Barrigon, Katy E Barwick, Giovanni Bisello, Joanne Ng, John Robert Counsell et al. · 2021 · Brain
  40. Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress
    Furong Yu, Jianhua Zhou · 2008 · Neuroscience Letters
  41. A yeast model of the Parkinson׳s disease-associated protein Parkin
    Clara Pereira, Vítor Costa, L. Miguel Martins, Lucı́lia Saraiva · 2015 · Experimental Cell Research
  42. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: The role of salsolinol and NM-salsolinol
    Yang Su, Jinyan Duan, Zhengxin Ying, Ying Hou, Yanyan Zhang, Rui Wang, Yulin Deng · 2013 · Neuroscience
  43. Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on α-synuclein protein levels
    Emmanuel González‐Barbosa, Rosario García-Aguilar, Libia Vega, María Asunción Cabañas-Cortés, Frank J. Gonzalez, José Segovia, Sara L. Morales‐Lázaro, Bulmaro Cisneros, Guillermo Elizondo · 2019 · Biochemical Pharmacology
  44. Parkin represses 6-hydroxydopamine-induced apoptosis via stabilizing scaffold protein p62 in PC12 cells
    Xiao‐Ou Hou, Jianmin Si, Haigang Ren, Dong Chen, Hongfeng Wang, Zheng Ying, Qingsong Hu, Feng Gao, Guanghui Wang · 2015 · Acta Pharmacologica Sinica
  45. Mitochondrial Dysfunction Precedes Other Sub-Cellular Abnormalities in an In Vitro Model Linked with Cell Death in Parkinson’s Disease
    C. J. Yong-Kee, Elena S Sidorova, Asad Hanif, G. Perera, Joanne E. Nash · 2011 · Neurotoxicity Research
  46. Early-Life Exposure to Methylmercury in Wildtype and pdr-1/parkin Knockout C. elegans
    Ebany J. Martinez‐Finley, Sudipta Chakraborty, James C. Slaughter, Michael Aschner · 2013 · Neurochemical Research
  47. Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons
    Zhidong Zhou, Fathima Shaffra Refai, Shao Ping Xie, Shin Hui Ng, Christine Hui Shan Chan, Patrick Ho, Xiao Dong Zhang, Tit Meng Lim, Eng King Tan · 2013 · Free Radical Biology and Medicine
  48. Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential
    Yukiko Kuroda, Wataru Sako, Satoshi Goto, Tomoyo Sawada, Daisuke Uchida, Yuishin Izumi, Tetsuya Takahashi, Noriko Kagawa, Masayasu Matsumoto, Mitsuru Matsumoto et al. · 2011 · Human Molecular Genetics
  49. PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine–induced apoptosis: Potential therapeutic strategy in Parkinson's disease
    A.R. Bonilla-Porras, Ángela J Arévalo-Arbeláez, Juan F. Álzate, Carlos Velez‐Pardo, Marlene Jiménez-Del-Río · 2017 · Cytotherapy
  50. Upregulation of OPA1 by carnosic acid is mediated through induction of IKKγ ubiquitination by parkin and protects against neurotoxicity
    Chia‐Yuan Lin, Wen-Jiun Chen, Ru‐Huei Fu, Chia-Wen Tsai · 2019 · Food and Chemical Toxicology
  51. Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein
    Matthew J. Benskey, Ki Yong Lee, Kevin A. Parikh, Keith J. Lookingland, John L. Goudreau · 2013 · NeuroToxicology
  52. Parkin Modulates Gene Expression in Control and Ceramide-Treated PC12 Cells
    Paul Gerson Unschuld, Justus C. Dächsel, Frederic D. Darios, Alexander Kohlmann, Elisabeth Casademunt, Klaus Lehmann‐Horn, Martin Dichgans, Merle Ruberg, Alexis Brice, Thomas Gasser et al. · 2006 · Molecular Biology Reports
  53. Neuronal inclusions in degenerative disorders
    Francesco Fornai, Paola Soldani, Gloria Lazzeri, Adolfo Bandettini di Poggio, Francesca Biagioni, Federica Fulceri, Serena Batini, Stefano A. Ruggieri, Antonio Paparelli · 2005 · Brain Research Bulletin
  54. The role of gamma‐synuclein in cocaine‐induced behaviour in rats
    Frédéric Boyer, Jean‐Luc Dreyer · 2008 · European Journal of Neuroscience
  55. The Role of Chaperones in Parkinson’s Disease and Prion Diseases
    Konstanze F. Winklhofer, Jörg Tatzelt · 2005 · Handbook of experimental pharmacology
  56. Covalent arylation of metallothionein by oxidized dopamine products: A possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival
    Michelle A. Gauthier, Joseph Karl Eibl, James A. G. Crispo, Gregory M. Ross · 2008 · Neurotoxicity Research
  57. hVMAT2: A Target of Individualized Medication for Parkinson's Disease
    Nian Xiong, Nuomin Li, Eden R. Martin, Jinlong Yu, Jie Li, Jing Liu, David Y.W. Lee, Ole Isacson A, Jeffery M. Vance, Hong Qing et al. · 2016 · Neurotherapeutics
  58. The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease
    Suresh Kumar, Michael R. Mattern, Matthew S. Goldberg, Tauseef R. Butt · 2023 · NeuroMolecular Medicine
  59. Glucocorticoid Regulates Parkin Expression in Mouse Frontal Cortex: Implications in Schizophrenia
    Chirayu D. Pandya, Amanda Crider, Anilkumar Pillai · 2014 · Current Neuropharmacology
  60. Annual Research Review: Rare genotypes and childhood psychopathology – uncovering diverse developmental mechanisms of ADHD risk
    Gaia Scerif, Kate Baker · 2014 · Journal of Child Psychology and Psychiatry
  61. Umbelliferone protects against cerebral ischemic injury through selective autophagy of mitochondria
    Zhuchen Zhou, Yan Zhang, Feng Han, Zhong Chen, Yanrong Zheng · 2023 · Neurochemistry International
  62. Stress-induced phospho-ubiquitin formation causes parkin degradation
    Lyudmila Kovalchuke, Eugene V. Mosharov, Oren A. Levy, Lloyd A. Greene · 2019 · Scientific Reports
  63. Parkin Interacts with Apoptosis-Inducing Factor and Interferes with Its Translocation to the Nucleus in Neuronal Cells
    Marianna Guida, Alessandra Zanon, Luigi Montibeller, Alexandros Α. Lavdas, Judith Ladurner, Francesca Pischedda, Aleksandar Raković, Francisco S. Domingues, Giovanni Piccoli, Christine Klein et al. · 2019 · International Journal of Molecular Sciences
  64. Neuroproteases in Peptide Neurotransmission and Neurodegenerative Diseases
    VIVIAN Y. H. HOOK · 2006 · BioDrugs
  65. A MAPK/c-Jun-mediated switch regulates the initial adaptive and cell death responses to mitochondrial damage in a neuronal cell model
    Thomas A. Ryan, Katherine M. Roper, Jacquelyn Bond, Sandra M. Bell, Sean T. Sweeney, Ewan E. Morrison · 2018 · The International Journal of Biochemistry & Cell Biology
  66. Can parkin be a target for future treatment of Parkinson's disease?
    Shinichiro Kubo, Taku Hatano, Masashi Takanashi, Nobutaka Hattori · 2013 · Expert Opinion on Therapeutic Targets
  67. CCT327 enhances TRAIL-induced apoptosis through the induction of death receptors and downregulation of cell survival proteins in TRAIL-resistant human leukemia cells
    Yan-Jin Liu, Yingchao Lin, Jang‐Chang Lee, Sheng‐Chu Kuo, Chi‐Tang Ho, Li‐Jiau Huang, Daih‐Huang Kuo, Tzong‐Der Way · 2014 · Oncology Reports
  68. Molecular Features of Parkinson's Disease in Patient‐Derived Midbrain Dopaminergic Neurons
    Yong Ren, Houbo Jiang, Jiali Pu, Li Li, Jianbo Wu, Yaping Yan, Guohua Zhao, Thomas J. Guttuso, Baorong Zhang, Jian Feng · 2021 · Movement Disorders
  69. Polychlorinated biphenyls alter expression of α-synuclein, synaptophysin and parkin in the rat brain
    Katarzyna Małkiewicz, Roma Mohammed, Ronnie Folkesson, Bengt G. Winblad, Mirosław M. Szutowski, Eiríkur Benedikz · 2005 · Toxicology Letters
  70. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells
    Andreas Koch, Klaus Lehmann‐Horn, Justus C. Dächsel, Thomas Gasser, Philipp J. Kahle, Christoph B. Lücking · 2008 · Parkinsonism & Related Disorders
  71. Gene therapy for Parkinson’s disease
    Hideki Mochizuki · 2007 · Expert Review of Neurotherapeutics
  72. Neuroprotection of Parkin against apoptosis is independent of inclusion body formation
    Hui Yang, Haiyan Zhou, Biao Li, Shengdi Chen · 2005 · Neuroreport
  73. Parkin: Much More than a Simple Ubiquitin Ligase
    Cristine Alvès da Costa, Frédéric Checler · 2011 · Neurodegenerative Diseases
  74. Flavin-containing monooxygenase, a new clue of pathological proteins in the rotenone model of parkinsonism
    Boyu Li, Yu‐He Yuan, Wanqing Zhang, Wenbin He, Jin‐Feng Hu, Nai‐Hong Chen · 2014 · Neuroscience Letters
  75. Ketoconazole induces apoptosis in rat cardiomyocytes through reactive oxygen species-mediated parkin overexpression
    Kyung‐Jong Won, Kang Pa Lee, Suyeol Yu, Donghyen Lee, Dong-Youb Lee, Hwan Myung Lee, Jung Hwan Kim, Seung Hyo Jung, Suji Baek, Bokyung Kim · 2015 · Archives of Toxicology
  76. Loss of HIPK2 Protects Neurons from Mitochondrial Toxins by Regulating Parkin Protein Turnover
    Jiasheng Zhang, Yulei Shang, Sherry Kamiya, Sarah J. Kotowski, Ken Nakamura, Eric Jinsheng Huang · 2019 · Journal of Neuroscience
  77. Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease
    Alika Sarkar, Mohd Sami Ur Rasheed, Mahendra Pratap Singh · 2022 · Antioxidants and Redox Signaling
  78. Of Parkin and Parkinson's: light and dark sides of a multifaceted E3 ubiquitin–protein ligase
    Olga Corti, Alexis Brice · 2007 · Drug Discovery Today Disease Mechanisms
  79. Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals
    Tam Duong, Jaetaek Kim, H. Earl Ruley, Daewoong Jo · 2014 · PLoS ONE
  80. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson’s disease
    X. Wang, Hongàn Yang, X N Wang, Yi Du · 2016 · Genetics and Molecular Research
  81. Proteomic Analysis of Parkin Isoforms Expression in Different Rat Brain Areas
    Agata Grazia D’Amico, Grazia Maugeri, Rita Reitano, Sebastiano Cavallaro, Velia D’Agata · 2016 · The Protein Journal
  82. Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell‐Derived A9 Dopaminergic Neurons
    Jiali Pu, Lin Lin, Houbo Jiang, Zhixing Hu, Hong Li, Zhen Yan, Baorong Zhang, Jian Feng · 2023 · Movement Disorders
  83. Kynurenine attenuates mitochondrial depolarization and neuronal cell death induced by rotenone exposure independently of AhR-mediated parkin induction in SH-SY5Y differentiated cells
    Rosario García-Aguilar, Arturo Ortega, Esther López‐Bayghen, Leticia Ramírez-Martínez, Ada G. Rodríguez-Campuzano, Fátima E. Murillo-González, Guillermo Elizondo, Libia Vega · 2023 · NeuroToxicology
  84. The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure
    Matthew J. Benskey, Fredric P. Manfredsson, Keith J. Lookingland, John L. Goudreau · 2014 · NeuroToxicology
  85. Oxidative Stress in Parkinson’s Disease: Role in Neurodegeneration and Targets for Therapeutics
    Rebecca Banerjee, Navneet Ammal Kaidery, Bobby Thomas · 2015 · ACS symposium series
  86. Enhanced IRE1α Phosphorylation/Oligomerization-Triggered XBP1 Splicing Contributes to Parkin-Mediated Prevention of SH-SY5Y Cell Death under Nitrosative Stress
    Tsung‐Lang Chiu, Hsin‐Yi Huang, Hui‐Fen Chang, Hsin-Rong Wu, Mei-Jen Wang · 2023 · International Journal of Molecular Sciences
  87. Functional Role of Parkin against Oxidative Stress in Neural Cells
    Minyoung Hwang, Ja-myong Lee, Younghwa Kim, Dongho Geum · 2014 · Endocrinology and Metabolism
  88. Oxidative Stress and Cellular Dysfunction in Neurodegenerative Disease
    Anju Singh, Ritushree Kukreti, Shrikant Kukreti · 2021 · Neuromethods
  89. Animal models of Parkinson's disease
    Anumantha G. Kanthasamy, Siddharth Kaul · 2006 · Cambridge University Press eBooks
  90. PINK1: One Protein, Multiple Neuroprotective Functions
    Enza Maria Valente, Silvia Michiorri, Giuseppe Arena, Vania Gelmetti · 2009 · Future Neurology
  91. Immunolocalization of Fertilin β, IZUMO1, and P34H in Ram Spermatozoa
    Gül İpek Gündoğan, Abit Aktaş · 2021 · Biopreservation and Biobanking
  92. In vitro physiological effects of Origanum onites L. (Lamiaceae) essential oil treatment on human origin cell lines
    Gül İpek Gündoğan, Ebru Özdemir Nath · 2021 · TURKISH JOURNAL OF BOTANY
  93. Genetic aspects of Parkinson's disease
    Yoshikuni Mizuno, Nobutaka Hattori, Hideki Mochizuki · 2007 · Handbook of clinical neurology
  94. Etiology and pathogenesis of Parkinson’s disease: role of mitochondrial pathology
    Marisa Brini, Ottolini, Tito Calí · 2013 · Research and Reports in Biochemistry
  95. The Proteomic Landscape of Parkin-Deficient and Parkin-Overexpressing Rat Nucleus Accumbens: An Insight into the Role of Parkin in Methamphetamine Use Disorder
    AKHIL KUMAR SHARMA, Tarek Atasi, Florine Collin, Weiwei Wang, TuKiet T. Lam, Rolando García-Milian, Tasnim Arroum, Lucynda Pham, Maik Hüttemann, Anna Moszczyńska · 2025 · Biomolecules
  96. Chemical Components of Thymbra spicata subsp. spicata L. Essential Oil and Its In Vitro Physiological Effects on Human Origin Cell Lines
    Ebru Özdemir Nath, Gül İpek Gündoğan, Murat Kartal · 2023 · Records of Natural Products
  97. Biomarkers of Parkinson’s disease
    Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy · 2014 · Elsevier eBooks
  98. Use of Caenorhabditis elegans to Model Human Movement Disorders
    Guy A. Caldwell, Kim A. Caldwell · 2014 · Elsevier eBooks
  99. Review of environmental chemicals and neurotoxicity : focus on neurological diseases.
    Susan Bull · 2007 · Europe PMC (PubMed Central)
  100. Dopamine and L-Dopa as Selective Endogenous Neurotoxins
    Juan Segura‐Aguilar, Ulises Ahumada-Castro, Irmgard B. Paris · 2022 · Springer eBooks